A Breakthrough Voyage Into the Bloodstream
On 14 November 2025, researchers at ETH Zurich announced in Science a major breakthrough: microrobots small enough to swim through blood vessels and deliver drugs precisely where needed — for example, to dissolve blood clots causing strokes. These “non-human workers” consist of spherical gel capsules, less than 2 mm in diameter, embedded with iron-oxide nanoparticles. The magnetic particles let doctors steer and control them remotely using external magnetic fields.
How the “Voice AI Agent”-Like System Works
Once injected into the bloodstream or cerebrospinal fluid via a catheter, the microrobot is guided through the body’s vessels using a sophisticated navigation system. The researchers combined three magnetic-navigation strategies:
- A rotating magnetic field to roll the capsule along vessel walls (up to about 4 mm/s)
- A shifting magnetic-field gradient to pull the microrobot even against the blood flow (reaching more than 20 cm/s)
- Real-time imaging via tantalum contrast agents inside the capsule that make it visible under X-ray.
Once the microrobot reaches its target — say a thrombus (blood clot) in the brain — a high-frequency magnetic field heats the capsule, dissolving the gel shell and releasing the therapeutic agent precisely where it’s needed.
Proven in Models and Animals — But Not Humans Yet
In laboratory tests, the team first used silicone vessel models that closely mimic real human and animal arteries to perfect their navigation strategy. Then they moved on to large-animal experiments:
- In pigs, they steered the microrobots through blood vessels, successfully delivering a clot-dissolving drug to the right location.
- In sheep, they navigated the devices through cerebrospinal fluid to demonstrate the technique’s versatility.
Right now, human trials haven’t begun — but the results so far suggest these tiny agents could transform how we treat strokes, brain tumors, or other localized diseases, by massively cutting side effects.
Why This Matters
This research could revolutionize targeted therapy. Today, to dissolve a stroke-related clot, we administer powerful drugs systemically — which affects the whole body and risks serious side effects like internal bleeding. By contrast, these microrobots act like AI employees in the body: they are guided, deliver their “task” (the drug), then disband. Because they are so precise, they could allow for lower dosages and fewer risks.
In a broader sense, this is part of a wave of medicine evolving to rely on non-human workers, or “voice AI agents,” in which external control systems direct microscopic devices inside us — opening doors to ultra-precise therapy, fewer side effects, and entirely new treatment approaches.
Key Highlights:
- ETH Zurich has created microrobots under 2 mm wide that can swim through blood vessels.
- The robots are magnetic gel capsules loaded with medicine and contrast agents.
- Navigation uses three combined magnetic strategies to overcome high blood flow.
- Once at the target (e.g., a brain clot), a magnetic field dissolves the capsule to release treatment.
- Successfully tested in animal models (pigs, sheep) — but not yet in humans.
- Could dramatically reduce side effects by delivering drugs only where needed.
Reference:
